Press Releases
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Aug 06, 2026
Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer
Aug 04, 2026
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
Jul 31, 2026
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Jul 22, 2026
Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial
Jun 25, 2026
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Jun 15, 2026
Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York
May 28, 2026
Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial
May 21, 2026
Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis
May 19, 2026
Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab
May 14, 2026
Displaying 1 - 10 of 547